Short answer
Chemed Corp (CHE) filed an 8-K current report with the SEC on October 27, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 results for quarter ended September 30, 2026, covering Chemed’s latest operating performance.
Chemed Corp 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 2026 results for quarter ended September 30, 2026, covering Chemed’s latest operating performance
- Press release furnished as Exhibit 99, containing the detailed financial results and management commentary
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $690.9M, up 10.6%; GAAP EPS $5.45, up 22.2%, adjusted EPS $6.75, up 28.1%
- VITAS drove earnings: revenue $457.4M, ADC up 9.4%, adjusted EBITDA up 31.4% to $92.5M
- VITAS Medicare Cap limitation fell to $828,000 from $6.1M, materially supporting quarterly revenue and margins
- Roto-Rooter revenue rose 7.5%, but adjusted EBITDA fell 2.5% to $48.2M as margin declined 213 basis points to 20.6%
- Roto-Rooter re-acquired California territories for approximately $62.5M, covering over 12 million people and adding branches in Sacramento and San Diego
- Management expects full-year 2026 adjusted EPS at or slightly above the high end of prior guidance
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Chemed Corp 8-K filings
Get the next CHE 8-K as it lands
Follow CHE for push alerts, or ask the research agent what this filing means.